The use of Pradaxa has been linked to serious injury. There are nearly 2,000 cases currently pending in federal court in the Southern District of Illinois. Pradaxa is a blood thinner that was marketed to replace warfarin, a commonly used anticoagulant. Unfortunately, there is no readily-available antidote for the internal bleeding that can sometimes occur in patients treated with Pradaxa.
As we have previously reported, Judge David R. Herndon, Chief Judge of United States District Court, presiding over the litigation, recently sanctioned the manufacturer of Pradaxa, Boehringer Ingelheim Pharmaceuticals, Inc., over $931,000 for failing to preserve documents. Plaintiffs’ attorneys were concerned that the German-based drug maker continued to improperly withhold other documents related to the drug. Judge Herndon agreed and on January 29, 2014, ordered Boehringer Ingelheim to unseal 85 documents which had previously been marked as confidential. Plaintiffs will continue to request information related to the safety and marketing of Pradaxa.
If you or a loved one has experienced serious side effects after taking Pradaxa, you can contact Stark & Stark and speak to one of the Mass Tort attorneys, free of charge, who can help assess any claims that you might have against Boehringer Ingelheim Pharmaceuticals, Inc.